Nikolas K Haass

20PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyStructural properties of condensed matterSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 10, 2026
S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers.

|Apr 07, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Zhen Zeng, Anastasia Gandini, Rituparna Bhatt

|Mar 28, 2026
The Emerging Melanoma Management: Historical Perspective to Future Directions.

Shin Yee Hui, Rohit Jain, Nikolas K Haass

|Dec 18, 2024
The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD models.

Sanket B Raut, Fanny Joly, Nikolas K Haass

|Aug 19, 2024
Compression-dependent microtubule reinforcement enables cells to navigate confined environments.

Robert J Ju, Alistair D Falconer, Christanny J Schmidt

|Dec 13, 2023
Formation and Growth of Co-Culture Tumour Spheroids: New Compartment-Based Mathematical Models and Experiments.

Ryan J Murphy, Gency Gunasingh, Nikolas K Haass

Pageof 4

Frequent Collaborators

5 joint publications

Matthew Simpson

4 joint publications

Ryan J Murphy

3 joint publications

Dajiang Guo

3 joint publications

Shweta Tikoo